We are analyzing https://link.springer.com/article/10.1007/s13238-010-0078-y.

Title:
Cancer stem cells in glioblastoma—molecular signaling and therapeutic targeting | Protein & Cell
Description:
Glioblastomas (GBMs) are highly lethal primary brain tumors. Despite current therapeutic advances in other solid cancers, the treatment of these malignant gliomas remains essentially palliative. GBMs are extremely resistant to conventional radiation and chemotherapies. We and others have demonstrated that a highly tumorigenic subpopulation of cancer cells called GBM stem cells (GSCs) promotes therapeutic resistance. We also found that GSCs stimulate tumor angiogenesis by expressing elevated levels of VEGF and contribute to tumor growth, which has been translated into a useful therapeutic strategy in the treatment of recurrent or progressive GBMs. Furthermore, stem cell-like cancer cells (cancer stem cells) have been shown to promote metastasis. Although GBMs rarely metastasize beyond the central nervous system, these highly infiltrative cancers often invade into normal brain tissues preventing surgical resection, and GSCs display an aggressive invasive phenotype. These studies suggest that targeting GSCs may effectively reduce tumor recurrence and significantly improve GBM treatment. Recent studies indicate that cancer stem cells share core signaling pathways with normal somatic or embryonic stem cells, but also display critical distinctions that provide important clues into useful therapeutic targets. In this review, we summarize the current understanding and advances in glioma stem cell research, and discuss potential targeting strategies for future development of anti-GSC therapies.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Education
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 8,280,528 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

google, scholar, cells, stem, cell, cancer, glioblastoma, human, tumor, glioma, nature, res, brain, growth, neural, signaling, rich, pathway, mouse, wang, differentiation, therapeutic, tumors, proc, natl, acad, sci, notch, embryonic, med, lee, park, bao, proliferation, adult, identification, mclendon, hjelmeland, stemlike, zhang, expression, biol, medulloblastoma, article, targeting, gliomas, clarke, factor, nat, lathia,

Topics {✒️}

sry-related hmg-box factors pten/pi3k/akt pathway regulates human colon-cancer-initiating cells a2b5+cd133-tumor-initiating cells transforming growth factor-beta glioma cd133-positive cells neural stem/progenitor cells niche cell-cell interactions ink4a/arf-independent manner embryonic stem cells serum-cultured cell lines qiulian wu & shideng bao neural stem cells motor neuron/oligodendrocyte connection tumor-initiating cells initiating tumour growth stromal-derived factor 1 promotes therapeutic resistance cancer therapeutic resistance tumour-initiating cells glioma-initiating cells glioma stem cells erythropoietin receptor signaling brain tumor hypoxia glioma tumor stem glioblastoma-initiating cells glioblastoma stem cells pluripotent stem cells human tumor cells glioblastoma multiforme cells cancer stem cells hedgehog pathway inhibitor glioblastoma—molecular signaling neuronal repressor rest/nrsf dna damage response promotes tumor growth crypt stem cells hematopoietic stem cells patched-1-deficient mouse medulloblastoma human glioblastoma multiforme cancer stem cell anti-gsc therapies akt inhibits growth cancerous stem cells neoplastic stem cells cancer brain tumor tumor-propagating cells human neuroblastoma cells glioma progenitor cells related subjects

Questions {❓}

Cancer stem cells: mirage or reality?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Cancer stem cells in glioblastoma—molecular signaling and therapeutic targeting
         description:Glioblastomas (GBMs) are highly lethal primary brain tumors. Despite current therapeutic advances in other solid cancers, the treatment of these malignant gliomas remains essentially palliative. GBMs are extremely resistant to conventional radiation and chemotherapies. We and others have demonstrated that a highly tumorigenic subpopulation of cancer cells called GBM stem cells (GSCs) promotes therapeutic resistance. We also found that GSCs stimulate tumor angiogenesis by expressing elevated levels of VEGF and contribute to tumor growth, which has been translated into a useful therapeutic strategy in the treatment of recurrent or progressive GBMs. Furthermore, stem cell-like cancer cells (cancer stem cells) have been shown to promote metastasis. Although GBMs rarely metastasize beyond the central nervous system, these highly infiltrative cancers often invade into normal brain tissues preventing surgical resection, and GSCs display an aggressive invasive phenotype. These studies suggest that targeting GSCs may effectively reduce tumor recurrence and significantly improve GBM treatment. Recent studies indicate that cancer stem cells share core signaling pathways with normal somatic or embryonic stem cells, but also display critical distinctions that provide important clues into useful therapeutic targets. In this review, we summarize the current understanding and advances in glioma stem cell research, and discuss potential targeting strategies for future development of anti-GSC therapies.
         datePublished:2010-07-29T00:00:00Z
         dateModified:2010-07-29T00:00:00Z
         pageStart:638
         pageEnd:655
         sameAs:https://doi.org/10.1007/s13238-010-0078-y
         keywords:
            cancer stem cell
            glioblastoma
            therapeutic resistance
            molecular targeting
            tumor angiogenesis
            hypoxia response
            stem cell niche
            Biochemistry
            general
            Protein Science
            Cell Biology
            Stem Cells
            Human Genetics
            Developmental Biology
         image:
         isPartOf:
            name:Protein & Cell
            issn:
               1674-8018
               1674-800X
            volumeNumber:1
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Higher Education Press
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Zhi Huang
               affiliation:
                     name:Lerner Research Institute, Cleveland Clinic
                     address:
                        name:Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lin Cheng
               affiliation:
                     name:Lerner Research Institute, Cleveland Clinic
                     address:
                        name:Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Olga A. Guryanova
               affiliation:
                     name:Lerner Research Institute, Cleveland Clinic
                     address:
                        name:Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Qiulian Wu
               affiliation:
                     name:Lerner Research Institute, Cleveland Clinic
                     address:
                        name:Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shideng Bao
               affiliation:
                     name:Lerner Research Institute, Cleveland Clinic
                     address:
                        name:Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Cancer stem cells in glioblastoma—molecular signaling and therapeutic targeting
      description:Glioblastomas (GBMs) are highly lethal primary brain tumors. Despite current therapeutic advances in other solid cancers, the treatment of these malignant gliomas remains essentially palliative. GBMs are extremely resistant to conventional radiation and chemotherapies. We and others have demonstrated that a highly tumorigenic subpopulation of cancer cells called GBM stem cells (GSCs) promotes therapeutic resistance. We also found that GSCs stimulate tumor angiogenesis by expressing elevated levels of VEGF and contribute to tumor growth, which has been translated into a useful therapeutic strategy in the treatment of recurrent or progressive GBMs. Furthermore, stem cell-like cancer cells (cancer stem cells) have been shown to promote metastasis. Although GBMs rarely metastasize beyond the central nervous system, these highly infiltrative cancers often invade into normal brain tissues preventing surgical resection, and GSCs display an aggressive invasive phenotype. These studies suggest that targeting GSCs may effectively reduce tumor recurrence and significantly improve GBM treatment. Recent studies indicate that cancer stem cells share core signaling pathways with normal somatic or embryonic stem cells, but also display critical distinctions that provide important clues into useful therapeutic targets. In this review, we summarize the current understanding and advances in glioma stem cell research, and discuss potential targeting strategies for future development of anti-GSC therapies.
      datePublished:2010-07-29T00:00:00Z
      dateModified:2010-07-29T00:00:00Z
      pageStart:638
      pageEnd:655
      sameAs:https://doi.org/10.1007/s13238-010-0078-y
      keywords:
         cancer stem cell
         glioblastoma
         therapeutic resistance
         molecular targeting
         tumor angiogenesis
         hypoxia response
         stem cell niche
         Biochemistry
         general
         Protein Science
         Cell Biology
         Stem Cells
         Human Genetics
         Developmental Biology
      image:
      isPartOf:
         name:Protein & Cell
         issn:
            1674-8018
            1674-800X
         volumeNumber:1
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Higher Education Press
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Zhi Huang
            affiliation:
                  name:Lerner Research Institute, Cleveland Clinic
                  address:
                     name:Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lin Cheng
            affiliation:
                  name:Lerner Research Institute, Cleveland Clinic
                  address:
                     name:Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Olga A. Guryanova
            affiliation:
                  name:Lerner Research Institute, Cleveland Clinic
                  address:
                     name:Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Qiulian Wu
            affiliation:
                  name:Lerner Research Institute, Cleveland Clinic
                  address:
                     name:Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shideng Bao
            affiliation:
                  name:Lerner Research Institute, Cleveland Clinic
                  address:
                     name:Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Protein & Cell
      issn:
         1674-8018
         1674-800X
      volumeNumber:1
Organization:
      name:Higher Education Press
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Lerner Research Institute, Cleveland Clinic
      address:
         name:Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, USA
         type:PostalAddress
      name:Lerner Research Institute, Cleveland Clinic
      address:
         name:Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, USA
         type:PostalAddress
      name:Lerner Research Institute, Cleveland Clinic
      address:
         name:Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, USA
         type:PostalAddress
      name:Lerner Research Institute, Cleveland Clinic
      address:
         name:Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, USA
         type:PostalAddress
      name:Lerner Research Institute, Cleveland Clinic
      address:
         name:Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Zhi Huang
      affiliation:
            name:Lerner Research Institute, Cleveland Clinic
            address:
               name:Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, USA
               type:PostalAddress
            type:Organization
      name:Lin Cheng
      affiliation:
            name:Lerner Research Institute, Cleveland Clinic
            address:
               name:Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, USA
               type:PostalAddress
            type:Organization
      name:Olga A. Guryanova
      affiliation:
            name:Lerner Research Institute, Cleveland Clinic
            address:
               name:Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, USA
               type:PostalAddress
            type:Organization
      name:Qiulian Wu
      affiliation:
            name:Lerner Research Institute, Cleveland Clinic
            address:
               name:Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, USA
               type:PostalAddress
            type:Organization
      name:Shideng Bao
      affiliation:
            name:Lerner Research Institute, Cleveland Clinic
            address:
               name:Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, USA
      name:Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, USA
      name:Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, USA
      name:Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, USA
      name:Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, USA

External Links {🔗}(203)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.64s.

LINK . SPRINGER . COM {}